Since inception of our IPO research in 2015, the Aequitas Research team has covered over 361 IPOs, which raised over US$100m each, across Asia Pacific (excluding Korea and China A-shares) and the US (Asia linked listings).
For this insight, we used data from our IPO framework, the prospectus, company filings and market data to analyse 244 IPOs across Developed and Emerging Asia Pacific (excluding Korea and China A-shares) that took place over 2016-18. Our results are split across two insights.
In this insight we looked at the country and GICS level IPO performance over 2016-18. We also analysed the variance between the first week and three month performance to decide whether buying orphans is better than sticking to winners. Some of our key findings include:
In our second insight, we’ll analyse the best and worst bookrunners by country, corporate governance impact on listing performance, earnings and liquidity analysis. Our key findings include:
This report has been prepared by the entire Aequitas Research Team: Ke Yan, CFA, FRM, Zhen Zhou, Toh and Sumeet Singh.
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.